Have you tested positive for COVID-19 in the last 10 days and you’re in a high-risk health group for worse health complications? You may be concerned about your recovery if you have a high-risk health problem like cancer, COPD, or heart disease. If you’re eligible, monoclonal antibody (mAb) therapy may help put you on the road to swifter recovery.
What Is a Monoclonal Antibody?
Antibodies are naturally made by the body to fight off bacteria or viruses, and the body also makes the antibodies to the coronavirus. However, these naturally produced antibodies to fight the coronavirus are not highly effective. Laboratory scientists have found a way to help patients with active COVID-19 infections get a jumpstart on healing with mAb therapy. The antibodies created in the laboratory are designed to be highly effective at neutralizing this specific type of coronavirus. Treatment is generally well-tolerated, is delivered intravenously (by IV infusion) in just one dose, and only takes about one to 3 hours to administer in a comfortable outpatient setting.
How Many Types of Monoclonal Antibody Treatments Are There in the U.S.?
The U.S. Food and Drug Administration has given Emergency Use Authorization (EUA) monoclonal antibody treatment for COVID-19 treatment for bamlanivimab plus etesevimab, casirivimab plus imdevimab, and sotrovimab.
Who Can Get Monoclonal Antibody Treatment?
The goal of mAb is to prevent hospitalizations, reduce viral loads, and lessen symptom severity. That means specific individuals are prioritized for treatment based on their treatment urgency because they are at higher risk for more severe COVID-19 symptoms. These individuals include elderly adults, the overweight/obese, pregnant women, and people with chronic diseases such as diabetes or heart failure.
mAb treatment is available to patients who meet the following criteria:
- Are high risk for developing severe COVID-19 and
- Have had a positive COVID-19 test but have not yet been admitted to a hospital and
- Are 12+ years of age and weigh at least 88 pounds
Advance ER Offers Monoclonal Antibody Treatment in Dallas
Good scientists are eager to keep current with all developments in protecting the general population and keeping people safe from a vicious virus that preys on the most vulnerable among us. At Advance ER, we have been at the front lines helping those affected by COVID-19 since the outset of the pandemic. We provide COVID-19 treatment and mAb treatment to qualified individuals from trusted ER professionals. If you are struggling with COVID-19 symptoms, seek immediate medical attention. Our team at Advance ER can quickly test you and provide a specialized treatment plan.
For more information about COVID-19 treatments like monoclonal antibody therapy at Advance ER, call us at (214) 494-8222 or reach out online now.